84 results
8-K
EX-10.10
THER
Theralink Technologies, Inc.
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
.
EZEM has the responsibility to manufacture and test Products in compliance with the Regulations and within Registration documentation (ANDA … responsibility to assure compliance with the Regulations.
Batch Release
Batch review and release to distribution will be the responsibility of EZEM who
8-K
EX-99.1
THER
Theralink Technologies, Inc.
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
ended December 31, 2009. These financial statements are the responsibility of management of the GRANISOL™ product line. Our responsibility is to express
8-K
EX-10.1
THER
Theralink Technologies, Inc.
14 Sep 11
PediatRx enters U.S. co-promotion agreement for AQUORALTM
12:00am
supply the market. Company shall have the sole responsibility, at its sole cost and expense, with respect to the Product for (i) manufacture, packaging … . Company at its cost shall have the sole right and responsibility to handle all recalls and market withdrawals of the Product. Company shall notify PediatRx
8-K
uwpnyxu
15 Sep 11
PediatRx appoints Paul J. Richardson to Board of Directors
12:00am
8-K/A
EX-99.1
9d1ckmieg gx7g
2 Jul 18
Index to Financial Statements
4:05pm
8-K
EX-10.2
51s9zs
3 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hrmwk4d4hy6b reni
3 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
6r44zi by3izfr
30 Sep 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.7
dus6ksh33f35te 7ppcc
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
0bwcnnc745 8yoz
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
iav4zboud6a
28 Sep 10
Entry into a Material Definitive Agreement
12:00am